Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Approach to lower limb oedema / / Satyendra K. Tiwary, editor
| Approach to lower limb oedema / / Satyendra K. Tiwary, editor |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (346 pages) |
| Disciplina | 616.047 |
| Soggetto topico |
Orthopedic surgery
Leg - Abnormalities Edema Cama Cirurgia ortopèdica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
981-16-6205-3
981-16-6206-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Foreword -- Preface -- Contents -- 1: Introduction of Lower Limb Edema -- 1.1 Background -- 1.2 Introduction -- 1.3 Etiology and Classification -- 1.4 Pathophysiology -- 1.5 Diagnosis -- 1.6 Management and Outcome -- 1.7 Deep Vein Thrombosis -- 1.8 Lymphedema -- 1.9 Conclusion -- References -- 2: Anatomy of Lower Limb -- 2.1 Anatomy of Venous System of the Lower Extremity -- 2.2 Embryological Development of Veins of the Lower Extremity: Clinical Aspects of Atypical Anatomy -- 2.3 Anatomical Routes Connecting Pelvic Veins with Those of the Lower Extremity -- 2.4 Anatomy of Lymphatic System of Lower Extremity -- References -- 3: Physiological Basis of Lower Limb Edema -- 3.1 Introduction -- 3.2 Architecture of Microcirculation Unit -- 3.3 Myogenic Autoregulation of Capillary Microcirculation -- 3.4 Capillary Endothelium as Regulator of Microcirculation -- 3.5 Transcapillary Exchange Across Endothelium -- 3.6 Diffusion Across Capillary Endothelium -- 3.7 Capillary Filtration as Regulated by Pressure Gradients -- 3.8 Lymphatic Circulation -- 3.9 Pathophysiology of Edema -- 3.10 Thermodynamical Considerations in Edema Therapeutics -- 3.11 Various Physiological Conditions Affecting Edema Formation -- 3.11.1 Effect of Gravity -- 3.11.2 Effect of Diet and Nutrition -- 3.11.3 Effect of Physical Activity and Posture -- 3.11.4 Edema in Pregnancy -- 3.11.5 Effect of Altitude Changes -- 3.12 Pathological Conditions Presenting with Edema -- 3.12.1 Heart Failure -- 3.12.2 Hepatic Cirrhosis -- 3.12.3 Constrictive Pericarditis and Restrictive Cardiomyopathy -- 3.12.4 Renal Diseases -- 3.12.5 Medications -- 3.12.6 Thyroid Disease -- 3.12.7 Lymphatic Obstruction -- 3.12.8 Venous Incompetence or Deep Vein Thrombosis -- 3.12.9 Dermatitis and Lipedema -- 3.13 Conclusion -- References.
4: Aetiopathogenesis in Lower Limb Oedema -- 4.1 Introduction -- 4.2 Pathogenesis -- 4.3 Starling Forces -- 4.4 Etiology -- 4.5 Heart Diseases -- 4.6 Liver Diseases -- 4.7 Renal Diseases -- 4.8 Venous (or Lymphatic) Drainage Obstruction -- 4.9 Deep Vein Thrombosis -- 4.10 Chronic Vein Insufficiency -- 4.11 Reflex Sympathetic Dystrophy -- 4.12 Lymphedema -- 4.13 Inflammatory Edema -- 4.14 Summary and Conclusion -- References -- 5: Clinical Examination in Lower Limb Edema -- 5.1 Introduction -- 5.2 Clinical History -- 5.3 Physical Examination -- 5.3.1 Distribution -- 5.3.2 Tenderness -- 5.3.3 Pitting -- 5.3.4 Skin changes -- 5.4 Diagnostic Studies -- 5.4.1 Laboratory Tests -- 5.4.2 Noninvasive Quantitative Methods to Assess Lower Limb Edema -- 5.4.3 Water Displacement (Volume Measurements) [16] -- 5.4.4 Perometer [17] -- 5.4.5 Circumferential Method (with a Tape Measure) [18] -- 5.4.6 Bioimpedance (BIA) -- References -- 6: Investigations of Lower Limb Edema -- 6.1 Introduction -- 6.2 Static Leg Circumference Measurements -- 6.3 Static Leg Volume Measurements -- 6.4 Water Displacement Volumetry (WDV) -- 6.5 The "Truncated Cone" -- 6.6 Optoelectronic Systems -- 6.7 Dynamic Volume Measurements -- 6.8 Techniques for the Qualitative Evaluation of Leg Edema -- 6.9 Computed Tomography and Magnetic Resonance Leg Imaging -- 6.10 Dual X-Ray Absorptiometry -- 6.11 Ultrasonography -- References -- 7: Differential Diagnosis of Lower Extremity Oedema -- 7.1 Introduction -- 7.2 Brief Details of Common Causes -- 7.2.1 DVT and Chronic Venous Disease -- 7.2.2 Cellulitis -- 7.2.3 Lymphedema -- 7.2.3.1 Primary Lymphedema -- 7.2.3.2 Secondary Lymphedema -- 7.2.4 Lipedema -- 7.2.5 Postoperative Swelling -- 7.2.6 Compartment Syndrome -- 7.2.7 Systemic Diseases -- 7.2.8 Venous Malformation -- 7.3 Summary -- References. 8: Complications of Lower Limb Edema -- 8.1 Introduction -- 8.2 Complications of Lower Limb Edema -- 8.2.1 Pain -- 8.2.2 Superficial Thrombophlebitis -- 8.2.2.1 Investigations -- 8.2.2.2 Management -- 8.2.2.3 Complications -- 8.2.3 Dermatitis -- 8.2.3.1 Investigations -- 8.2.3.2 Treatment -- 8.2.4 Lipodermatosclerosis -- 8.2.4.1 Investigations -- 8.2.4.2 Treatment -- 8.2.5 Atrophic Blanche -- 8.2.5.1 Investigations -- 8.2.5.2 Management -- 8.2.6 Venous Ulcer -- 8.2.6.1 Pathogenesis -- 8.2.6.2 Investigations -- 8.2.6.3 Management -- 8.2.7 Cellulitis -- 8.2.7.1 Investigations -- 8.2.7.2 Treatment -- 8.2.8 Lymphangiosarcoma -- 8.2.8.1 Clinical Presentation -- 8.2.8.2 Pathogenesis -- 8.2.8.3 Investigations -- 8.2.8.4 Management -- References -- 9: Chronic Lower Limb Edema -- 9.1 Introduction -- 9.2 Pathophysiology -- 9.3 Classification -- 9.4 Assessment of Edema -- 9.4.1 Diagnostic Studies -- 9.5 Therapeutic Options -- 9.5.1 Conservative and Skin Care Treatment -- 9.5.2 Compression Therapy -- 9.5.3 Types of Compression -- 9.5.3.1 Hosiery -- 9.5.3.2 Bandages -- 9.5.3.3 Intermittent Pneumatic Compression [IPC] -- 9.5.4 Exercise and Positional Therapy -- 9.6 Surgical Management of the Swollen Lower Limb -- 9.7 Common Causes of Leg Edema -- 9.7.1 Lymphedema -- 9.7.2 Varicose Vein -- 9.7.3 CEAP Classification: C (Clinical Component) -- 9.7.4 Deep Vein Thrombosis -- 9.8 Filariasis -- 9.8.1 Lymphatic Filariasis -- 9.8.2 Cellulitis -- 9.9 Summary and Recommendations -- References -- 10: DEEP Vein Thrombosis -- 10.1 Definition of Deep Vein Thrombosis -- 10.2 History of Deep Vein Thrombosis -- 10.3 Epidemiology of Deep Vein Thrombosis -- 10.4 Pathophysiology of Deep Vein Thrombosis: Mechanism and Pathology -- 10.5 Sites of Deep Vein Thrombosis -- 10.6 Pathology of the Edema of Deep Vein Thrombosis. 10.7 Risk Factors Associated with Deep Vein Thrombosis -- 10.8 Diagnosis of Deep Vein Thrombosis -- 10.9 D-Dimer -- 10.10 Ultrasound (US) -- 10.11 CT Venography -- 10.12 Magnetic Resonance Venography -- 10.13 Venography -- 10.14 Hematological Investigations -- 10.15 Treatment Strategies -- 10.16 Anticoagulation -- 10.17 Compression Therapy -- 10.18 Thrombolysis and Thrombectomy -- 10.19 Surgical Treatment of Chronic Lower Extremity DVT -- References -- 11: Chronic Venous Insufficiency -- 11.1 Introduction and Epidemiology -- 11.2 Anatomy and Physiology -- 11.3 Etiopathophysiology of Lower Leg Edema in CVI -- 11.4 Diagnosis of CVI in Patients Presenting with Lower Leg Edema -- 11.4.1 Deep Vein Thrombosis in the Context of CVI and Leg Edema -- 11.4.2 Investigations -- 11.5 Classification of CVI in the Context of Lower Limb Edema -- 11.6 Conservative Management -- 11.7 Operative Management -- 11.8 Management of Deep Vein Obstruction in the Context of Oedema -- References -- 12: Compression Stockings -- 12.1 History of Compression Therapy -- 12.2 Types of Compression Stockings and Devices -- 12.2.1 Pathophysiology -- 12.3 Mechanism -- 12.4 Safety -- 12.5 Fitting of Compression Stockings -- 12.6 Instructions to the Wearer -- 12.7 Considerations When Fitting and Supplying Compression Stockings -- 12.8 Compression Stockings: Fabrics and Design -- 12.8.1 Donning Aids -- 12.8.2 Indications for Compression Therapy -- 12.9 Thromboembolic Deterrent Stockings in the Prevention of Hospital-Acquired Thrombosis -- 12.10 Prevention of Post-Thrombotic Syndrome -- 12.11 Symptomatic Relief in Post-Thrombotic Syndrome -- 12.12 Symptomatic Relief in Acute DVT -- 12.13 Symptomatic Relief in Chronic Venous Disease -- 12.14 Treatment of Venous Ulceration -- 12.15 Treatment of Acute Leg Pain Post-Endovenous Ablation. 12.16 Treatment of Lipedema -- 12.17 Treatment of Lymphedema -- 12.18 Adherence to Compression Stockings -- References -- 13: Imaging Assessment of Lower Limb Swelling -- 13.1 Introduction -- 13.2 Causes -- 13.3 Diagnostic Imaging Evaluation in Lower Limb Swelling -- 13.4 Skin and Subcutaneous Tissue -- 13.4.1 Cellulitis -- 13.5 Vascular Disorders (Venous System) -- 13.5.1 Deep Venous Thrombosis -- 13.5.2 Diagnosis of DVT -- 13.5.3 Normal Findings -- 13.6 Acute Superficial Thrombophlebitis -- 13.7 Chronic Venous Insufficiency -- 13.8 Technique of Examination -- 13.9 Muscular and Tendinous Disorder -- 13.9.1 Muscle Contusion or Hematoma -- 13.9.2 Muscle Strain and Tears -- 13.9.3 Tennis Leg -- 13.9.4 Calcific Myonecrosis -- 13.9.5 Pyomyositis -- 13.9.6 Tenosynovitis -- 13.10 Osseous and Joint Space Related -- 13.10.1 Baker's Cyst -- 13.11 Joint Effusion and Septic Arthritis -- 13.12 Miscellaneous Causes -- 13.13 Summary -- References -- 14: Genetic Association in Lower Limb Swelling -- 14.1 Introduction -- 14.2 Edema of Both Legs -- 14.3 Edema of One Leg -- 14.4 Edema of One or Both Legs -- 14.4.1 Chronic Venous Insufficiency -- 14.4.2 Varicose Veins -- 14.4.3 Post-Thrombotic Syndrome (PTS) -- 14.4.4 Lymphedema -- 14.4.5 Milroy's Primary Congenital Lymphedema -- 14.4.6 Meige Disease -- 14.4.7 Hereditary Angioedema (HAE) -- 14.4.8 Erythromelalgia -- 14.5 Conclusion -- References -- 15: Vascular Malformations and Edema -- 15.1 Introduction -- 15.2 Type of Defects -- 15.2.1 Venous Defects (VM) -- 15.2.2 Arteriovenous Malformations (AVM) -- 15.2.3 Lymphatic Malformations (LM) -- 15.3 Pathology and Clinical Picture -- 15.4 Hemodynamics of Vascular Malformations of the Lower Limbs -- 15.5 Symptomatology -- 15.6 Clinical Picture of Edema in CVM -- 15.7 Diagnosis -- 15.8 Treatment -- 15.9 Conclusion. References. |
| Record Nr. | UNINA-9910743234803321 |
| Gateway East, Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diabetic macular edema / / Sandeep Saxena and Timothy Y. Y. Lai, editors
| Diabetic macular edema / / Sandeep Saxena and Timothy Y. Y. Lai, editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (227 pages) |
| Disciplina | 616.462 |
| Soggetto topico |
Diabetes - Complications
Edema Retina - Blood-vessels - Diseases |
| ISBN | 981-19-7307-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Contents -- About the Editors -- 1: Diabetic Macular Edema: An Introduction -- 1.1 Diabetic Macular Edema: Introduction -- References -- 2: Pathophysiology of Diabetic Macular Edema -- 2.1 Introduction -- 2.2 Pathophysiology of Diabetic Macular Edema -- 2.2.1 Alteration of Blood-Retinal Barrier -- 2.2.2 Outer Blood-Retinal Barrier -- 2.2.3 Inner Blood-Retinal Barrier -- 2.3 Mechanisms of Disease -- 2.3.1 Oxidative Stress -- 2.3.2 Mitochondrial Alterations -- 2.3.3 Vascular Dysfunction -- 2.4 Inflammation -- 2.4.1 Molecules Involved and Therapeutic Potential -- 2.4.2 Growth Factors -- 2.4.3 Cytokines and Chemokines -- 2.5 Pharmacotherapies in Diabetic Macular Edema -- 2.6 Strategies for the Future: Current Clinical Trials in DME -- 2.7 Conclusion -- References -- 3: Optical Coherence Tomography Biomarkers in Diabetic Macular Edema -- 3.1 Introduction -- 3.2 OCT Biomarkers in Diabetic Macular Edema -- 3.3 Retinal Biomarkers -- 3.3.1 Retinal Thickness -- 3.3.2 Disorganization of Retinal Inner Layers -- 3.3.3 Hyperreflective Retinal Foci and Hard Exudates -- 3.3.4 Intraretinal Cystoid Spaces -- 3.3.5 Pearl Necklace Sign -- 3.3.6 Bridging Retinal Processes -- 3.3.7 Subfoveal Neurosensory Detachment -- 3.3.8 Vitreomacular Interface -- 3.3.9 Integrity of External Limiting Membrane and Ellipsoid Zone -- 3.3.10 Photoreceptor Outer Segment -- 3.3.11 Outer Retinal Layer Thickness [41] -- 3.3.12 Retinal Pigment Epithelium Thickness -- 3.3.13 Foveal Eversion -- 3.3.14 Parallelism -- 3.4 Choroidal Biomarkers -- 3.4.1 Subfoveal Choroidal Thickness -- 3.4.2 Choroidal Vascularity Index -- 3.4.3 Hyperreflective Choroidal Foci -- 3.5 OCT Angiography Biomarkers in Diabetic Macular Edema -- 3.5.1 Foveal Avascular Zone -- 3.5.1.1 Vessel Density in Superficial Capillary Plexus [53].
3.5.1.2 Loss of Deep Capillary Plexus -- 3.5.1.3 Middle Capillary Plexus -- 3.6 Summary -- References -- 4: Optical Coherence Tomography Angiography in Diabetic Macular Edema -- 4.1 Introduction -- 4.2 Diabetic Macular Edema Biomarkers in OCT -- 4.2.1 Bridging Retinal Processes -- 4.2.2 Choroidal Vascular Index -- 4.2.3 Disorganization of Retinal Inner Layers -- 4.2.4 Hyperreflective Retinal Foci and Hard Exudates -- 4.2.5 Hyperreflective Choroidal Foci -- 4.2.6 Intraretinal Cystoid Spaces -- 4.2.7 Integrity of External Limiting Membrane and Ellipsoid Zone -- 4.2.8 Retinal Thickness -- 4.2.9 Photoreceptor Outer Segment -- 4.2.10 Subfoveal Choroidal Thickness -- 4.2.11 Subfoveal Neurosensory Detachment -- 4.2.12 Taut Posterior Hyaloid Membrane -- 4.3 DME Biomarkers in OCT Angiography -- 4.3.1 Foveal Avascular Zone -- 4.3.2 Intercapillary Spacing -- 4.3.3 Microaneurysms, Intraretinal Microvascular Abnormalities, Neovascularization, Nonperfusion Areas -- 4.3.4 Retinal Vascular Density -- 4.3.5 Suspended Scattering Particles in Motion -- References -- 5: Targeted Screening of Macular Edema by Spectral Domain Optical Coherence Tomography for Progression of Diabetic Retinopathy: Translational Aspects -- 5.1 Introduction -- 5.2 Spectral Domain Optical Coherence Tomography-Based Evaluation of Diabetic Macular Edema -- 5.3 Vascular Endothelial Growth Factor and Diabetic Macular Edema -- References -- 6: Anti-Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema -- 6.1 Treatment of Diabetic Macular Edema Before Anti-VEGF -- 6.2 History of VEGF Blockade Development [2] -- 6.3 Anti-VEGF Agents for DME: The Present Day -- 6.3.1 Avastin (Bevacizumab) -- 6.3.2 Lucentis (Ranibizumab) -- 6.3.3 Eylea (Aflibercept) -- 6.4 Adverse Effects of Anti-VEGF Agents -- 6.5 Treatment Regimens -- 6.5.1 When to Treat?. 6.5.2 PRN Regimen -- 6.5.3 Treat and Extend Regimen -- 6.6 Cost-Effectiveness -- 6.7 Anti-VEGF Agents: Head-to-Head -- 6.8 Future of Anti-VEGF -- 6.8.1 Conbercept -- 6.8.2 Beovu (Brolucizumab) -- 6.8.3 Faricimab -- 6.9 Novel Therapies in Production [21] -- 6.9.1 Abicipar Pegol -- 6.9.2 Port Delivery System -- 6.9.3 Thermosensitive Hydrogels -- 6.9.4 Microparticles -- 6.9.5 Gene Therapy -- 6.10 Conclusion -- References -- 7: Agents Targeting Angiopoietin/Tie Pathway in Diabetic Macular Edema -- 7.1 Roles of Angiopoietin/Tie Pathway in Retinal Diseases and Diabetic Macular Edema -- 7.2 Razuprotafib (AKB-9778) -- 7.2.1 Razuprotafib Mechanism of Action -- 7.2.2 Phase 1 DME Study -- 7.2.3 Phase 2 TIME-2 Study -- 7.3 Nesvacumab + Aflibercept Coformulation (REGN910-3) -- 7.3.1 Nesvacumab Mechanism of Action -- 7.3.2 Phase 1 Trial -- 7.3.3 Phase 2 RUBY Study -- 7.4 Faricimab (RG7716) -- 7.4.1 Faricimab Mechanism of Action -- 7.4.2 Phase 2 BOULEVARD Study -- 7.4.3 Phase 3 RHINE and YOSEMITE Studies -- 7.4.4 RHONE-X Study -- 7.5 Other Potential Agents Targeting Angiopoietin/Tie Pathway for DME -- 7.5.1 AXT107 -- 7.5.2 BI 836880 -- 7.6 Summary -- References -- 8: DRCR.net Trials for Diabetic Macular Edema -- 8.1 Introduction -- 8.2 Protocol A: A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema -- 8.3 Protocol B: A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema -- 8.4 Protocol H: A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) -- 8.5 Protocol I: Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema. 8.6 Protocol T: A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema -- 8.7 Protocol TX: A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema: Follow-Up Extension Study -- 8.8 Protocol U: Short-Term Evaluation of Combination Corticosteroid + Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy -- References -- 9: Effect of Anti-VEGF Therapy on Inner and Outer Retinal Layers on Spectral-Domain Optical Coherence Tomography in Diabetic Macular Edema -- 9.1 Introduction -- 9.2 Pathogenesis of Diabetic Macular Oedema: Role of Vascular Endothelial Growth Factor -- 9.3 Pathomorphology of Different Layers of Retina in Diabetic Macular Edema -- 9.4 SD-OCT-Based Changes in Inner Retinal Layers in Diabetic Macular Edema -- 9.5 SD-OCT-Based Changes in Outer Retinal Layers in Diabetic Macular Edema -- 9.6 Role of Anti-VEGF Therapy in DME -- 9.7 Changes in Inner and Outer Layers of Retina Post Anti-VEGF Therapy Based on SD-OCT -- 9.8 Conclusion -- References -- 10: Diabetic Macular Ischemia and Anti-VEGF Therapy -- 10.1 Introduction -- 10.2 DMI -- 10.2.1 Pathogenesis -- 10.2.2 Diagnosis: FA -- 10.2.3 Diagnosis: OCTA -- 10.2.4 Visual Prognosis -- 10.3 DMI and Anti-VEGF -- 10.3.1 Influence of DMI on Anti-VEGF Therapy in Eyes with DME -- 10.3.2 Influence of Anti-VEGF on DMI -- References -- 11: Dexamethasone Implant in Diabetic Macular Edema -- 11.1 Introduction -- 11.2 Role of Inflammation in DME -- 11.3 Cataract Surgery and DME -- 11.4 Steroids as Therapeutic Option in DME -- 11.5 Dexamethasone Implant: Introduction -- 11.6 Role of Dexamethasone Implant in Current Clinical Practice: An Evidence-Based Approach. 11.7 Dexamethasone Implant and Imaging Biomarkers of DME -- 11.7.1 Subretinal Fluid (SRF)/Subfoveal Serous Retinal Detachment (SSRD) -- 11.7.2 Hyperreflective Foci (HRF) -- 11.7.3 Hard Exudates -- 11.7.4 Disorganization of Retinal Inner Layers (DRIL) -- 11.8 Contraindications of DEX Implant -- 11.9 Summary -- References -- 12: Laser Photocoagulation for Diabetic Macular Edema -- 12.1 Introduction -- 12.2 Pathophysiology of DME -- 12.3 Clinical Diagnosis of DME -- 12.4 Definitions of DME -- 12.5 Laser Therapy for Diabetic Retinopathy -- 12.5.1 Types of Laser -- 12.5.2 Properties of Laser [19] -- 12.5.3 Laser Absorption Characteristics of Tissues -- 12.5.4 Laser Treatment of Macular Edema -- 12.5.5 Mechanism of Action -- 12.5.6 Complications -- 12.5.7 Newer Forms of Laser Therapy -- 12.5.7.1 Selective Laser Therapy -- 12.5.7.2 Subthreshold Diode Micropulse Laser -- 12.5.7.3 Pattern Laser for DME -- 12.5.7.4 Image Guided Laser Therapy: Navigated Laser -- 12.5.8 Perspective of Intravitreal Pharmacotherapy -- 12.5.9 Current Indications for Laser Therapy in DME -- References -- 13: Surgical Management for Diabetic Macular Edema -- 13.1 The Role of the Vitreous in the Genesis of Diabetic Macular Edema -- 13.1.1 The Role of Epiretinal Membrane in Diabetic Macular Edema -- 13.2 History of Vitrectomy for the Treatment of Diabetic Macular Edema -- 13.2.1 Limits of Early Studies -- 13.3 Present Knowledge and Adequate Surgical Indications -- 13.3.1 Vitreomacular Interface Alterations -- 13.3.2 Diffuse DME Without a Clinically Evident Tractional Component -- 13.3.3 Unresponsive Cases -- 13.3.4 Special Situations -- 13.4 Surgical Technique -- 13.4.1 The Role of ILM Peeling -- 13.4.1.1 Present Knowledge on ILM Peeling -- 13.4.2 Combined Treatments -- 13.4.3 Postoperative Complications -- 13.5 Postoperative Outcomes. 13.5.1 Factors Affecting Postoperative Prognosis. |
| Record Nr. | UNINA-9910637704803321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
For the scurvey, pox, and dropsie [[electronic resource]]
| For the scurvey, pox, and dropsie [[electronic resource]] |
| Pubbl/distr/stampa | [London, : s.n., 1700?] |
| Descrizione fisica | 1 sheet ([1] p.) |
| Soggetto topico |
Scurvy
Sexually transmitted diseases - England Edema Advertising - Medicine |
| Soggetto genere / forma | Broadsides17th century.England |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996395334303316 |
| [London, : s.n., 1700?] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Osmotically induced coalescence of sarcoma cells through intercellular bridges in vitro / / by Clarence D. Cone, Jr. and Max Tongier, Jr
| Osmotically induced coalescence of sarcoma cells through intercellular bridges in vitro / / by Clarence D. Cone, Jr. and Max Tongier, Jr |
| Autore | Cone Clarence D., Jr. |
| Pubbl/distr/stampa | Washington, D.C. : , : National Aeronautics and Space Administration, , February 1969 |
| Descrizione fisica | 1 online resource (iii, 21 pages) : illustrations |
| Collana | NASA technical note |
| Soggetto topico |
Cell interaction
Cells - Permeability Cells - Growth Perfusion (Physiology) Edema Osmosis Mitosis Sarcoma Fibroblasts |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910715067603321 |
Cone Clarence D., Jr.
|
||
| Washington, D.C. : , : National Aeronautics and Space Administration, , February 1969 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Some observations made upon the Barbado seeds [[electronic resource] ] : shewing their admirable virtue in curing dropsies / / written by a physitian in the countrey to Sir George Ent at London
| Some observations made upon the Barbado seeds [[electronic resource] ] : shewing their admirable virtue in curing dropsies / / written by a physitian in the countrey to Sir George Ent at London |
| Autore | Peachi John <fl. 1683.> |
| Pubbl/distr/stampa | London, : [s.n.], 1694 |
| Descrizione fisica | 7 p |
| Altri autori (Persone) |
EntGeorge, Sir, <1604-1689.>
PecheyJohn <1655-1716.> |
| Soggetto topico |
Edema
Therapeutics |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996396552903316 |
|
Peachi John <fl. 1683.>
|
||
| London, : [s.n.], 1694 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Swelling (fluid retention) [[electronic resource] /] / National Cancer Institute
| Swelling (fluid retention) [[electronic resource] /] / National Cancer Institute |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : U.S. Dept. of Health and Human Services, National Institutes of Health, , [2008] |
| Descrizione fisica | 1 sheet : digital, PDF file |
| Collana |
Managing chemotherapy side effects (National Cancer Institute (U.S.))
NIH publication |
| Soggetto topico |
Edema
Body fluid disorders Cancer - Chemotherapy - Complications - Treatment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Swelling |
| Record Nr. | UNINA-9910697861303321 |
| [Bethesda, Md.] : , : U.S. Dept. of Health and Human Services, National Institutes of Health, , [2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
